Repigmentation of Hair Following Adalimumab Therapy

    January 2015 in “ Dermatology online journal ”
    Suzanne J. Tintle, Tushar S. Dabade, Robert A. Kalish, David Rosmarin
    Studysummary This report describes a patient experiencing hair repigmentation linked to adalimumab therapy, a TNF inhibitor, a phenomenon not previously associated with this class of drugs.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on escholarship.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Hair Repigmentation Associated with the Use of Lenalidomide: Graying May Not Be an Irreversible Process Journal of oncology pharmacy practice · 2012
    2. Weight Gain and Hair Loss During Anti-TNF Therapy International Journal of Rheumatology · 2012
    3. Hair Follicle Pigmentation: Mechanisms and Factors Influencing Melanin Production ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2005
    4. The Biology of Hair Follicles The New England Journal of Medicine · 1999